Unraveling an Aggressive Cancer: The Role of Epigenetics in Pancreas Cancer
A special issue of Cancers (ISSN 2072-6694).
Deadline for manuscript submissions: closed (31 January 2022) | Viewed by 7941
Special Issue Editors
Interests: biomarker; early detection; epigenetics; colorectal cancer; pancreas cancer
Interests: epigenetics; transcription; differential gene expression; gene expression and chromatin biology; pancreatic diseases; methylation; histone modification; epigenomics; gene transcription; ChIP-sequencing; promoter analysis; chromatin remodeling; cancer epigenetics; chromatin biology; histone proteins
Special Issue Information
Dear Colleagues,
Pancreas cancer is one of the most lethal malignancies and will become the 2nd leading cause of cancer death by 2030. Epigenetic mechanisms are essential for normal development and tissue-specific expression patterns. Cancer formation is synonymous with widespread changes in the epigenomic landscape with cellular reprogramming. The role of epigenetic mechanisms, such as histone changes, chromatin modifications, noncoding RNAs and DNA methylation, are only recently being identified in pancreas cancer. Understanding of these epigenetic changes and manipulation of the epigenome has the potential to alter the course of this dismal cancer. In this series, we will have experts from various domains, ranging from the clinical arena to mechanistic epigenetics to translational biology, to address emerging themes in understanding the epigenome of pancreas cancer and discuss rapidly transpiring insights into use of the epigenome for the diagnosis and potential treatment of pancreas cancer.
Prof. Dr. Nita K. Ahuja
Dr. Gwen Lomberk
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.